GREENLIGHT CAPITAL RE, LTD.
For the period ended Jun 30, 2025. Filed Aug 4, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 4, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Income from Investment in Solasglas
For Q2 2025 and YTD 2025, Solasglas reported a net loss of 4.0% and a net gain of 2.9%, respectively, compared to a net gain of 1.2% and 6.4% for Q2 2024 and YTD 2024, respectively. The following table provides a breakdown of the gross and net investment return for Solasglas.
| Three months ended June 30 | Six months ended June 30 | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Long portfolio gains (losses) | 1.2% | (1.0)% | (0.2)% | 3.4% |
| Short portfolio gains (losses) | (8.9) | 1.6 | (4.2) | 1.7 |
| Macro gains (losses) | 3.5 | 0.9 | 8.2 | 2.9 |
| Other income and expenses(1) | (0.2) | (0.2) | (0.6) | (0.9) |
| Gross investment return (loss) | (4.4)% | 1.3% | 3.2% | 7.1% |
| Net investment return (loss)(1) | (4.0)% | 1.2% | 2.9% | 6.4% |
1 “Other income and expenses” excludes performance compensation but includes management fees. “Net investment return” incorporates both of these amounts. For further information about management fees and performance compensation, refer to Note 3.
For Q2 2025, the significant contributors to Solasglas’ investment return were long positions in gold and Kyndryl Holdings (KD) and a short position in the S&P 500 index. The largest detractors were three single-name short positions.
For YTD 2025, the significant contributors to Solasglas’ investment return were the same as for Q2 2025. The largest detractors were a long position in Core Natural Resources (CNR) and two single-name short positions.
Each month, we post on our website (www.greenlightre.com) the returns from our investment in Solasglas.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.